Ranolazine
Brand name: Ranolazine Er
Rank #247 of 500 drugs by total cost
$51.6M
Total Cost
381,631
Total Claims
$51.6M
Total Cost
10,838
Prescribers
$135
Cost per Claim
65,901
Beneficiaries
713,052
30-Day Fills
$4,765
Avg Cost/Provider
35
Avg Claims/Provider
About Ranolazine
Ranolazine (sold as Ranolazine Er) was prescribed 381,631 times by 10,838 Medicare Part D providers in 2023, costing the program $51.6M. At $135 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 244 | Belumosudil Mesylate (Rezurock) | $52.3M | 2,280 |
| 245 | Pegloticase (Krystexxa) | $52.2M | 1,134 |
| 246 | Estrogens, Conjugated (Premarin) | $52.0M | 130,171 |
| 247 | Ranolazine (Ranolazine Er) | $51.6M | 381,631 |
| 248 | Epoetin Alfa (Epogen) | $51.4M | 34,952 |
| 249 | Nifedipine (Nifedipine Er) | $51.2M | 1,249,866 |
| 250 | Clobetasol Propionate (Clobetasol Propionate) | $51.2M | 758,575 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology